artesunic acid has been researched along with Pulmonary Fibrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Li, HX; Liu, H; Wang, CM; Wang, HJ | 1 |
| Huang, G; Jin, J; Wang, C; Xuan, X; Yao, W | 1 |
| Huang, G; Mo, B; Wang, C; Wang, Y | 1 |
3 other study(ies) available for artesunic acid and Pulmonary Fibrosis
| Article | Year |
|---|---|
Artesunate restraining MAPK passage by smad7 to resist pulmonary fibrosis.
Topics: Antimalarials; Artemisinins; Artesunate; Cell Line; Humans; Pulmonary Fibrosis; Signal Transduction; Smad7 Protein; Transforming Growth Factor beta1 | 2014 |
Anti-profibrotic effects of artesunate on bleomycin-induced pulmonary fibrosis in Sprague Dawley rats.
Topics: Actins; Animals; Artemisinins; Artesunate; Bleomycin; Collagen Type I; Gene Expression Regulation; HSP47 Heat-Shock Proteins; Lung; Male; Protective Agents; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Smad3 Protein; Transforming Growth Factor beta1 | 2015 |
Artesunate modulates expression of matrix metalloproteinases and their inhibitors as well as collagen-IV to attenuate pulmonary fibrosis in rats.
Topics: Animals; Artemisinins; Artesunate; Collagen Type IV; Disease Models, Animal; Extracellular Matrix; Gene Expression Regulation; Humans; Lung; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Pulmonary Fibrosis; Rats; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2016 |